Clinical trial Recruiting at 1 site Interventional Ages 18 and up

MRI-guided risk-based pacing for heart failure with reduced ejection fraction

Official title: Magnetic Resonance Imaging Based Risk Stratification for Defibrillator Implantation in Heart Failure Patients Requiring Cardiac Resynchronization Therapy (MADURAI CRT)

Run by Velammal Medical College Hospital and Research Institute · NCT07791407 · Data updated 2026-11-12

This study tests whether left bundle branch pacing without a defibrillator works as well as traditional CRT with defibrillator in people with a specific heart failure and MRI-detected low risk of scar.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment114 (estimated)
SponsorVelammal Medical College Hospital and Research Institute
Academic / other
Locations1 site (Madurai, Tamil Nadu)
StatusRecruiting
StartedAugust 1, 2026
Main results expectedJuly 15, 2027
Study endsJuly 15, 2028
Registry record updatedAugust 27, 2026
Trial IDNCT07791407 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults ≥18 with non-ischemic cardiomyopathy, LVEF ≤35%, typical LBBB, and HF symptoms despite GDMT.

Probably not a fit

Patients with significant scar or high-risk imaging, alternative anatomy, or inability to undergo CMR may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a single-center, prospective, randomized trial enrolling adults with non-ischemic cardiomyopathy, LVEF ≤35%, and heart failure symptoms despite GDMT. Participants undergo contrast-enhanced CMR to stratify risk by scar burden; low-risk patients (scar absent or <5%) are randomized 1:1 to LBBP without defibrillator or CRT-D with biventricular pacing. The LBBP procedure uses a 3830 lead via a proximal IVS approach, with fallback CS-based BiV pacing if LBBP is unsuccessful; in CRT-D arms, postero-lateral CS lead placement and a defibrillator lead are used. Primary endpoints focus on pacing effectiveness and clinical outcomes, with feasibility of alternative pacing strategies in case of technical failure. Inclusion criteria include adults ≥18 with typical LBBB and LVEF ≤35%, while key exclusions involve significant CAD requiring revascularization, non-LBBB patterns, pregnancy, contrast allergy, and other conditions limiting protocol adherence.

Why it matters

Potential benefit: If successful, patients could receive effective pacing without a defibrillator, potentially reducing device-related risks and complications.

How similar studies have gone: Previous pacing strategies have shown promise but this specific MRI-guided, scar-stratified comparison is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients with age ≥18 years
2. Typical left bundle branch block as defined by Strauss criteria with LVEF ≤35%
3. Heart failure symptoms despite guideline directed medical therapy (GDMT)

Exclusion Criteria:

1. Patients with angiographic evidence of significant coronary artery disease requiring revascularisation. In patients with significant CAD, LVEF will be re-assessed 3 months after revascularisation to decide about CRT
2. Patients with associated uncorrected congenital or valvular heart disease
3. Expected life-expectance of \<12 months due to associated comorbidities
4. Patients with contrast allergy
5. Baseline non-LBBB morphology
6. Renal dysfunction which limits the acquisition of CMR with contrast
7. Pregnant or lactating women
8. Patients who are unable to comply with study protocol

Where it's running

  • Velammal Medical College Hospital and Research Institute
    Madurai, Tamil Nadu, India
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.